BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Voskuil MD, Spekhorst LM, van der Sloot KWJ, Jansen BH, Dijkstra G, van der Woude CJ, Hoentjen F, Pierik MJ, van der Meulen AE, de Boer NKH, Löwenberg M, Oldenburg B, Festen EAM, Weersma RK. Genetic Risk Scores Identify Genetic Aetiology of Inflammatory Bowel Disease Phenotypes. J Crohns Colitis 2021;15:930-7. [PMID: 33152062 DOI: 10.1093/ecco-jcc/jjaa223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Shou X, Wang Y, Zhang X, Zhang Y, Yang Y, Duan C, Yang Y, Jia Q, Yuan G, Shi J, Shi S, Cui H, Hu Y. Network Pharmacology and Molecular Docking Analysis on Molecular Mechanism of Qingzi Zhitong Decoction in the Treatment of Ulcerative Colitis. Front Pharmacol 2022;13:727608. [PMID: 35237152 DOI: 10.3389/fphar.2022.727608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yan J, Yu W, Lu C, Liu C, Wang G, Jiang L, Jiang Z, Qin Z. The Pharmacological Mechanism of Guchangzhixie Capsule Against Experimental Colitis. Front Pharmacol 2021;12:762603. [PMID: 34867387 DOI: 10.3389/fphar.2021.762603] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Yu W, Cheng H, Zhu B, Yan J. Network Pharmacology-Based Validation of the Efficacy of Huiyangjiuji Decoction in the Treatment of Experimental Colitis. Front Pharmacol 2021;12:666432. [PMID: 34122086 DOI: 10.3389/fphar.2021.666432] [Cited by in F6Publishing: 2] [Reference Citation Analysis]